- Report
- December 2023
- 105 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Report
- August 2023
- 112 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Report
- February 2022
- 87 Pages
Global
From €3200EUR$3,925USD£2,877GBP
- Report
- March 2024
- 132 Pages
Global
From €830EUR$950USD£721GBP
- Report
- June 2023
- 9 Pages
Global
From €4367EUR$5,000USD£3,793GBP
- Report
- November 2021
- 844 Pages
Global
From €4367EUR$5,000USD£3,793GBP
- Book
- August 2013
- 248 Pages
- Book
- April 2019
North America
The Neurostimulator market is a subset of the Neurology Devices market, which includes a variety of medical devices used to diagnose and treat neurological conditions. Neurostimulators are devices that use electrical stimulation to treat neurological disorders, such as chronic pain, epilepsy, and Parkinson's disease. Neurostimulators are typically implanted in the body and can be used to stimulate the brain, spinal cord, or peripheral nerves. Neurostimulators can also be used to treat depression, anxiety, and other mental health conditions.
Neurostimulators are typically used in combination with other treatments, such as medications, physical therapy, and lifestyle changes. The market for Neurostimulators is growing, as more people are turning to these devices to treat neurological conditions.
Some companies in the Neurostimulator market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and NeuroPace. Show Less Read more